| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Recombinant Human Kininogen-1 (KNG1), partial |
|---|
| Description | Purity > 90% as determined by SDS-PAGE. MW: 31.8kDa. Partial: 390-639aa. N-terminal 6xHis-tagged. Homo sapiens (Human). 1 Kininogens are inhibitors of thiol proteases; (2) HMW-kininogen plays an important role in blood coagulation by helping to position optimally prekallikrein and factor XI next to factor XII; (3) HMW-kininogen inhibits the thrombin- and plasmin-induced aggregation of thrombocytes; (4) the active peptide bradykinin that is released from HMW-kininogen shows a variety of physiological effects: (4A) influence in smooth muscle contraction, (4B) induction of hypotension, (4C) natriuresis and diuresis, (4D) decrease in blood glucose level, (4E) it is a mediator of inflammation and causes (4E1) increase in vascular permeability, (4E2) stimulation of nociceptors (4E3) release of other mediators of inflammation (e.g. prostaglandins), (4F) it has a cardioprotective effect (directly via bradykinin action, indirectly via endothelium-derived relaxing factor action); (5) LMW-kininogen inhibits the aggregation of thrombocytes; (6) LMW-kininogen is in contrast to HMW-kininogen not involved in blood clotting. |
|---|
| Size | 100ug |
|---|
| Concentration | n/a |
|---|
| Applications | RUO |
|---|
| Other Names | Alpha-2-thiol proteinase inhibitorFitzgerald factorHigh molecular weight kininogen; HMWKWilliams-Fitzgerald-Flaujeac factor |
|---|
| Gene, Accession, CAS # | KNG1, UniProt: P01042 |
|---|
| Catalog # | RPC24339 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human Kininogen-1 (KNG1), partial from BIOMATIK |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|